Anti-CD11 b monoclonal antibody suppresses brain dissemination of Cryptococcus neoformans in mice

Kazuyoshi Kawakami1, Yoshinobu Koguchi, Mahboob Hossain Qureshi

  • 1First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan. kawakami@med.u-ryukyu.ac.jp

Insights

The beta2 integrin CD11b plays a role in Cryptococcus neoformans dissemination from the lung to the brain in mice. Targeting CD11b reduced fungal loads in the brain and blood, but not the lung.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Disseminated fungal infections, such as Cryptococcus neoformans, pose significant health risks.
  • Adhesion molecules, particularly beta2 integrins, are crucial for immune cell interactions and pathogen dissemination.
  • Understanding the role of specific adhesion molecules in fungal spread is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the involvement of beta2 integrin family adhesion molecules (CD11a, CD11b, CD11c, CD18) in the dissemination of Cryptococcus neoformans from the lung to the central nervous system.
  • To determine the effect of monoclonal antibodies targeting these molecules on fungal loads in the lung, brain, and blood of infected mice.

Main Methods:

  • Mice were intratracheally infected with Cryptococcus neoformans.
  • Monoclonal antibodies against CD11a, CD11b, CD11c, and CD18 were administered.
  • Fungal loads in the lung, brain, and blood were quantified three weeks post-infection.
  • Additionally, the effect of anti-CD11b mAb was assessed after intravenous C. neoformans injection.

Main Results:

  • Administration of anti-CD11b monoclonal antibody significantly reduced fungal loads in the brain and blood, but not in the lung, following intratracheal infection.
  • This treatment did not affect brain fungal loads when infection was established via intravenous injection.
  • Monoclonal antibodies against CD11a, CD11c, and CD18 did not significantly alter fungal loads in the lung or brain, with anti-CD18 mAb treatment paradoxically increasing brain fungal burden.

Conclusions:

  • The beta2 integrin CD11b appears to be partially involved in the dissemination of Cryptococcus neoformans from the lung to the brain.
  • Other beta2 integrin family members' roles in this dissemination process require further investigation.
  • Targeting CD11b may represent a potential therapeutic strategy to limit fungal neuroinvasion.